메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

라이프

ARC Therapies Advances Gut Microbiome Research with YB328 Toward Clinical Application

[ 메디채널 김갑성 기자 ] Investigating Its Role as an Immune Adjuvant in Cancer Immunotherapy TOKYO, Aug. 20, 2025 -- ARC Therapies Inc. (Head Office: Shinjuku, Tokyo; President & CEO: Rami Suzuki), a certified startup from the National Cancer Center Japan, has initiated research of YB328, a newly identified gut microbe, toward clinical application. Utilizing its proprietary intellectual property, the company has designated the YB328 strain as ARC0812 (RUX: "Lux") and will proceed with preclinical and human clinical trials to evaluate its administration methods and therapeutic e
- 김갑성 기자
- 2025-08-20 07:00
Ping An Good Doctor (1833.HK) Reports Strong Interim Results: Revenue and Profit Accelerate as AI Fuels New Growth Momentum

HONG KONG, Aug. 19, 2025 -- Ping An Healthcare and Technology Company Limited ("Ping An Good Doctor" or the "Company"; Stock Code: 1833.HK) announced its interim results for the six months ended June 30, 2025. During the first half of 2025, the Company delivered steady operational performance, showcasing strong growth momentum with gains in both revenue and profitability. Total revenue reached RMB2.5 billion, an increase of 19.5% year-on-year, while net profit attributable to shareholders rose to RMB134 million, an increase of 136.8% year-on-year. Notably, revenue from the
- 황정호 기자
- 2025-08-19 23:11
Mabwell's CDH17-targeting ADC 7MW4911 Receives IND Clearance from FDA

SHANGHAI, Aug. 19, 2025 -- Mabwell (688062.SH), an innovative biopharmaceutical company with entire industry chain, announced that its self-developed CDH17-targeting ADC (R&D code: 7MW4911) received IND clearance from the U.S. Food and Drug Administration (FDA). The clearance enables the initiation of Phase I/II study of 7MW4911 to evaluate the safety, pharmacokinetics, and efficacy in patients with advanced colorectal cancer and other advanced gastrointestinal tumors. 7MW4911 is an investigational CDH17-targeting ADC developed using Mabwell's proprietary IDDC™ platform. Its highly
- 김갑성 기자
- 2025-08-19 22:00
LabConnect Launches LabConnector™ to Streamline Lab Data Integration

New service ensures faster, more accurate data delivery to clients JOHNSON CITY, Tenn., Aug. 19, 2025 -- LabConnect, LLC, a global leader in central laboratory services for clinical trials, today announced the launch of LabConnector™, a powerful new technology solution that transforms the way laboratory data is exchanged and managed for clinical trials. LabConnector standardizes diverse laboratory data into a single HL7 format, enabling true bidirectional data transfer across any participating laboratory. LabConnector is purpose-built for IT teams and data analysts at sp
- 김갑성 기자
- 2025-08-19 21:15
WuXi Biologics Reports Solid 2025 Interim Results

[ 메디채널 김갑성 기자 ] Revenue increased by 16.1% YoY to RMB 9,953.2 million; revenue growth from continuing operations was 20.2% IFRS Gross profit margin expanded by 3.6% YoY to 42.7% EBITDA grew 50.5% YoY and IFRS net profit increased 54.8% YoY Adjusted EBITDA grew 20.6% YoY and adjusted net profit increased 11.6% YoY FY25 group revenue growth target raised to 14% – 16% A first-half record of 86 new integrated projects added, including 2 in late-stage Total integrated projects reached 864, one of the largest portfolios of complex biologics Late-stage and CMO revenue rose 24.9% YoY;
- 김갑성 기자
- 2025-08-19 20:35
Nature Medicine Publishes Results of Phase II Study of Sacituzumab Tirumotecan Plus Tagitanlimab as First-Line Therapy for NSCLC

CHENGDU, China, Aug. 19, 2025 -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ("Kelun-Biotech", HKEX: 6990) announced that clinical data from a Phase II study evaluating novel TROP2 antibody-drug conjugate (ADC) sacituzumab tirumotecan (sac-TMT) in combination with PD-L1 monoclonal antibody (mAb) tagitanlimab for the first-line treatment of advanced or metastatic non-small cell lung cancer (NSCLC) have been published in Nature Medicine (Impact Factor: 58.7). The publication highlighted initial findings from the Phase II OptiTROP-Lung01 study, evalua
- 김갑성 기자
- 2025-08-19 20:09
Medtronic announces Board appointments and shareholder value creation initiatives to advance strategic priorities

Experienced executives John Groetelaars and Bill Jellison appointed to the Board of Directors Board forms new Growth and Operating committees to sharpen focus on the company's ongoing strategic portfolio management, operational execution and capital allocation Plan to host Investor Day in 2026 Initiatives follow constructive engagement with Elliott Management GALWAY, Ireland, Aug. 19, 2025 -- Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the Medtronic Board of Directors has appointed John Groetelaars and Bill Jellison
- 김갑성 기자
- 2025-08-19 18:46
HoneyNaps Launches Cloud Version of AI Sleep Diagnostic Software "SOMNUM™" at SLEEP 2025

[ 메디채널 김갑성 기자 ] HIPAA-compliant cloud-based service provides diagnostic reports via the web with no installation required AI-powered trial service offered, highlighting potential for hospital-specific integration Presented performance of heart rate-based sleep stage estimation algorithm through oral and poster presentations BOSTON, Aug. 19, 2025 -- HoneyNaps, a medical AI diagnostics company, showcased both its technological capabilities and research achievements at SLEEP 2025, the world's largest sleep medicine conference held in Seattle, USA, from June 8 to 11. SLEEP 2
- 김갑성 기자
- 2025-08-19 18:00
Dubai Humanitarian: Powerful New Documentary Reveals World's Largest Humanitarian Logistics Hub

- 'Coming Together: The Dubai Humanitarian Story' provides behind-the-scenes look inside the heart of global disaster response facility - Launches on World Humanitarian Day, 19 August 2025 - First six months of 2025 saw $48.8m humanitarian aid distributed from Dubai Humanitarian, reflected in its Humanitarian Logistics Databank DUBAI, UAE, Aug. 19, 2025 -- Dubai Humanitarian, the world's largest humanitarian logistics hub, has unveiled a new documentary, Coming Together: The Dubai Humanitarian Story - a gripping behind-the-scenes look at the premier disaster response faci
- 김갑성 기자
- 2025-08-19 17:00
Dubai Humanitarian: Powerful New Documentary Reveals World's Largest Humanitarian Logistics Hub

- 'Coming Together: The Dubai Humanitarian Story' provides behind-the-scenes look inside the heart of global disaster response facility - Launches on World Humanitarian Day, 19 August 2025 - First six months of 2025 saw $48.8m humanitarian aid distributed from Dubai Humanitarian, reflected in its Humanitarian Logistics Databank DUBAI, UAE, Aug. 19, 2025 -- Dubai Humanitarian, the world's largest humanitarian logistics hub, has unveiled a new documentary, Coming Together: The Dubai Humanitarian Story - a gripping behind-the-scenes look at the premier disaster response faci
- 김갑성 기자
- 2025-08-19 17:00

이전

11 12 13 14 15 16 17 18 19 20

많이 본 기사

최근기사

2025-08-30_SAT

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 08월 31일 01시 20분